Physiomics PLC - London-based mathematical modelling company that supports oncology drug development - Says it has been awarded a further contract by its existing client, Numab Therapeutics. Numab.
Mathematical modelling company Physiomics, which specialises in the development of oncology drugs and personalised medicine, confirmed a renewed contract with Numab Therapeutics on Tuesday.
(Alliance News) - Physiomics PLC on Tuesday said it had completed a fundraise, conditional on admission, of GBP335,000 through a placing with Hybridan LLP, and announced a retail offer from Winterflood retail access platform to raise a maximum of GPB150,.
Physiomics PLC on Wednesday said it will collaborate with the University of Sheffield on research into an insect model of cancer treatment.
Physiomics is a London-based oncology consultancy, which. | May 31, 2023
Physiomics PLC shares fell on Tuesday, after it lowered its full-year outlook by more than 10%.
Physiomics is a London-based oncology consultancy, which uses mathematical models to support the. | May 23, 2023